Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENTRACTE: Tocilizumab vs Etanercept CV Safety in RA
NCT01331837Phase 4Completed
- Sponsor
- Roche
- Start
- Aug 2011
- Primary completion
- Mar 2016
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 31
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Roche. Started Aug 2011; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01331837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01331837.